Malek Faham
Asuragen (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments, CAR-T cell therapy research
Most-Cited Works
- → Diverse somatic mutation patterns and pathway alterations in human cancers(2010)1,025 cited
- → Mutations in the Gene Encoding Cystatin B in Progressive Myoclonus Epilepsy (EPM1)(1996)539 cited
- → Population structure, differential bias and genomic control in a large-scale, case-control association study(2005)530 cited
- → A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation(1995)510 cited
- → Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study(2015)451 cited
- → Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma(2014)424 cited
- → Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia(2012)420 cited
- → Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma(2018)412 cited
- → Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients(2014)379 cited
- → Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing(2015)337 cited